Market closedNon-fractional

23andMe/ME

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About 23andMe

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Ticker

ME

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Providers and Services

Headquarters

South San Francisco, United States

Employees

571

23andMe Metrics

BasicAdvanced
$210M
Market cap
-
P/E ratio
-$1.40
EPS
1.28
Beta
-
Dividend rate
$210M
1.28
2.005
1.726
35.988
40.587
-30.03%
-147.75%
0.928
1.11
1.56
-1.171
-26.66%
102.92%
-3.44%
-8.73%

What the Analysts think about 23andMe

Analyst Ratings

Majority rating from 2 analysts.
Buy

23andMe Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-326.25% profit margin
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$64M
43.18%
Net income
-$209M
-24.87%
Profit margin
-326.25%
-47.52%

23andMe Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 26.67%
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
-$0.23
-$0.16
-$0.16
-$0.11
-
Expected
-$0.15
-$0.14
-$0.14
-$0.15
-$0.22
Surprise
53.85%
13.88%
14.29%
-26.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for 23andMe stock?

23andMe (ME) has a market cap of $210M as of July 06, 2024.

What is the P/E ratio for 23andMe stock?

The price to earnings (P/E) ratio for 23andMe (ME) stock is 0 as of July 06, 2024.

Does 23andMe stock pay dividends?

No, 23andMe (ME) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next 23andMe dividend payment date?

23andMe (ME) stock does not pay dividends to its shareholders.

What is the beta indicator for 23andMe?

23andMe (ME) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell 23andMe stock

Buy or sell 23andMe stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing